The results of our prognostic analysis in the Kaplan-Meier Plotter database show that the up-regulation of SMC4 expression levels is significantly related to the poor prognosis of patients with sarcoma, breast cancer, liver cancer, or ovarian cancer. Here, SMC4 is linked to ovarian cancer.